Immersive Virtual Reality in Alleviating Pain and Anxiety in Children During Immunization in Primary Care: A Pilot Randomized Controlled Trial

Zi Ying Chang, Gary Chun-Yun Kang, Yi Ling Eileen Koh, Rodney Jin Kai Fong, Jiasheng Tang, Chi-Keong Goh, Ngiap Chuan TanFrontiers in Pediatrics 2022 · DOI

TL;DR

This pilot randomized controlled trial demonstrates that immersive virtual reality (VR) is a feasible and effective tool for reducing fear in children and anxiety in parents during routine vaccinations. By using a custom-built VR experience that synchronizes a "magical" story event with the physical injection, researchers found significant improvements in the emotional experience for children, parents, and healthcare providers alike.

What Problem Does This Paper Address?

Pediatric immunization is a cornerstone of public health, yet it is frequently derailed by needle phobia and procedural distress. This anxiety isn't just a momentary hurdle; it often leads to vaccine hesitancy in both children and their parents, potentially causing delays in the immunization schedule.

While traditional distractions (like toys or videos) help, they are often "passive"—the child remains fully aware of the clinical environment and the approaching syringe. The authors sought to test whether "immersive" VR—which completely replaces the user's visual and auditory surroundings—could provide a more robust "virtual analgesia" by diverting the brain's limited attentional resources away from pain signals.

Methods

The researchers conducted a pilot open-label randomized controlled trial (RCT) at a public primary care clinic in Singapore with 30 children (aged 4–10).

  • The Intervention: The "SILVER" (Soothing Immunization Leveraging on Virtual Reality Experience) software was developed specifically for this study. It features a mascot named "Burp" in a "Magic Tower."
  • The "Magic" Sync: Crucially, the software includes a narrative cue: about one minute into the story, the mascot uses a magic wand to tap the child’s left shoulder. This coincides exactly with the nurse administering the injection, reframing the physical sensation as a "magical" event within the VR world.
  • Hardware: The study utilized the Oculus Quest, a standalone VR headset.
  • Evaluation: The team used validated scales including the Faces Pain Scale-Revised (FPS-R) for pain, the Children’s Fear Scale (CFS) for anxiety, and Visual Analog Scales (VAS) to measure the stress levels of parents and nurses.

Datasets

As a clinical trial, the "dataset" consists of the primary data collected from the 30 participants. The study utilized several standardized psychometric benchmarks:

  • FPS-R (Faces Pain Scale-Revised): A self-reporting tool for children to rate pain intensity.
  • CFS (Children’s Fear Scale): A measure of state anxiety in pediatric patients.
  • VAS (Visual Analog Scale): Used for parents and nurses to self-rate anxiety levels.

Key Insights and Ideas

  • Reframing vs. Distraction: Unlike passive distraction (watching a movie), this intervention used procedural preparation. By syncing the needle poke with a story element (the magic wand tap), the researchers didn't just try to make the child "forget" the needle; they integrated the sensation into a positive narrative.
  • The "Halo Effect" on Parents: One of the most significant findings was the reduction in parental anxiety. Parental distress often feeds into a child's fear; by calming the parent through the child's visible ease, the entire clinical encounter became more manageable.
  • Staff Buy-in is Critical: New technology in a busy clinic can be a hard sell for staff. However, the nurses in this study rated the VR application highly for simplicity (9.5/10) and acceptability (10/10), suggesting that well-designed VR doesn't necessarily add to the clinical "friction."
  • High Feasibility: With an 88% recruitment response rate and only one child refusing the headset, the study suggests that both parents and children are highly receptive to tech-driven interventions in primary care.

Key Results

  • Fear Reduction: The change in Children’s Fear Scale (CFS) scores was significantly lower in the VR group (median change of -1) compared to the control group (median change of 0) with a P-value of 0.04.
  • Parental Anxiety: Parental VAS scores dropped significantly more in the VR group (median change of -4) than in the control group (median change of 0; P = 0.04).
  • Pain Scores: While the "Intention to Treat" analysis didn't show a statistically significant difference in pain, the "Per Protocol" analysis (excluding the one child who refused the headset) showed a significant reduction in pain scores (P = 0.04).
  • Safety: No adverse events (like motion sickness or dizziness) were reported, which is often a concern with pediatric VR usage.

Limitations and Future Work

The authors acknowledge several limitations inherent to a pilot study:

  • Sample Size: With only 30 participants, the study was not powered to detect subtle differences in pain scores across all demographics.
  • Blinding: Due to the nature of VR, it was impossible to blind the participants or the researchers to the intervention.
  • Gender Imbalance: The control group ended up with significantly more boys than the intervention group, which could potentially bias the results.
  • Cost-Effectiveness: The study did not evaluate the long-term ROI of procuring and maintaining VR equipment in a public health setting.

Future Directions: The authors suggest a larger, multi-center RCT with more diverse VR content to cater to different age groups and interests, as well as investigating the use of VR for children with special needs or severe needle phobias.

Summary updated

Abstract

[https://clinicaltrials.gov/ct2/show/NCT04748367], identifier [NCT04748367].
BibTeX
@inproceedings{chang2022immersive,
  author = {Zi Ying Chang and Gary Chun-Yun Kang and Yi Ling Eileen Koh and Rodney Jin Kai Fong and Jiasheng Tang and Chi-Keong Goh and Ngiap Chuan Tan},
  title = {{Immersive Virtual Reality in Alleviating Pain and Anxiety in Children During Immunization in Primary Care: A Pilot Randomized Controlled Trial}},
  booktitle = {Frontiers in Pediatrics},
  year = {2022},
  doi = {10.3389/fped.2022.847257},
}
Figure